Skip to main content

previous disabled Page of 2
and
  1. Article

    Author Correction: The Cyclophilin A–CD147 complex promotes the proliferation and homing of multiple myeloma cells

    Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, Teresa Calimeri, Jiang Meng in Nature Medicine (2024)

  2. No Access

    Article

    1H, 13C and 15N backbone and sidechain assignment of the Burkholderia mallei acyl carrier protein

    Acyl carrier proteins (ACPs) are universally conserved proteins amongst different species and are involved in fatty acid synthesis. Bacteria utilize ACPs as acyl carriers and donors for the synthesis of produc...

    Srdan Matosin, Patrick D. Fischer, Maxim A. Droemer in Biomolecular NMR Assignments (2023)

  3. Article

    Open Access

    Epitope editing enables targeted immunotherapy of acute myeloid leukaemia

    Despite the considerable efficacy observed when targeting a dispensable lineage antigen, such as CD19 in B cell acute lymphoblastic leukaemia1,2, the broader applicability of adoptive immunotherapies is hampered ...

    Gabriele Casirati, Andrea Cosentino, Adele Mucci, Mohammed Salah Mahmoud in Nature (2023)

  4. Article

    Open Access

    Accelerating inhibitor discovery for deubiquitinating enzymes

    Deubiquitinating enzymes (DUBs) are an emerging drug target class of ~100 proteases that cleave ubiquitin from protein substrates to regulate many cellular processes. A lack of selective chemical probes impede...

    Wai Cheung Chan, **aoxi Liu, Robert S. Magin, Nicholas M. Girardi in Nature Communications (2023)

  5. No Access

    Article

    Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo

    The peptidyl-prolyl isomerase, Pin1, is exploited in cancer to activate oncogenes and inactivate tumor suppressors. However, despite considerable efforts, Pin1 has remained an elusive drug target. Here, we scr...

    Christian Dubiella, Benika J. Pinch, Kazuhiro Koikawa in Nature Chemical Biology (2021)

  6. Article

    Open Access

    BRCA1 binds TERRA RNA and suppresses R-Loop-based telomeric DNA damage

    R-loop structures act as modulators of physiological processes such as transcription termination, gene regulation, and DNA repair. However, they can cause transcription-replication conflicts and give rise to g...

    Jekaterina Vohhodina, Liana J. Goehring, Ben Liu, Qing Kong in Nature Communications (2021)

  7. No Access

    Article

    Identification of a potent and selective covalent Pin1 inhibitor

    Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 (Pin1) is commonly overexpressed in human cancers, including pancreatic ductal adenocarcinoma (PDAC). While Pin1 is dispensable for viability in mice, it is ...

    Benika J. Pinch, Zainab M. Doctor, Behnam Nabet in Nature Chemical Biology (2020)

  8. No Access

    Article

    Glucose-dependent partitioning of arginine to the urea cycle protects β-cells from inflammation

    Chronic inflammation is linked to diverse disease processes, but the intrinsic mechanisms that determine cellular sensitivity to inflammation are incompletely understood. Here, we show the contribution of gluc...

    Accalia Fu, Juan Carlos Alvarez-Perez, Daina Avizonis, Tatsuya Kin in Nature Metabolism (2020)

  9. Article

    Open Access

    Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism

    Ubiquitin specific peptidase 7 (USP7) is a deubiquitinating enzyme (DUB) that removes ubiquitin tags from specific protein substrates in order to alter their degradation rate and sub-cellular localization. USP...

    Nathan J. Schauer, **aoxi Liu, Robert S. Magin, Laura M. Doherty in Scientific Reports (2020)

  10. No Access

    Article

    Development of a covalent inhibitor of gut bacterial bile salt hydrolases

    Bile salt hydrolase (BSH) enzymes are widely expressed by human gut bacteria and catalyze the gateway reaction leading to secondary bile acid formation. Bile acids regulate key metabolic and immune processes b...

    Arijit A. Adhikari, Tom C. M. Seegar, Scott B. Ficarro in Nature Chemical Biology (2020)

  11. No Access

    Article

    Architecture of autoinhibited and active BRAF–MEK1–14-3-3 complexes

    RAF family kinases are RAS-activated switches that initiate signalling through the MAP kinase cascade to control cellular proliferation, differentiation and survival13. RAF activity is tightly regulated and inap...

    Eunyoung Park, Shaun Rawson, Kunhua Li, Byeong-Won Kim, Scott B. Ficarro in Nature (2019)

  12. Article

    Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets

    Diffuse large B-cell lymphomas (DLBCLs) are a highly heterogeneous group of tumors in which subsets share molecular features revealed by gene expression profiles and metabolic fingerprints. While B-cell recept...

    Erik Norberg, Ana Lako, Pei-Hsuan Chen, Illana A Stanley in Cell Death & Differentiation (2017)

  13. No Access

    Article

    Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors

    A small molecule inhibits CDK12 and CDK13 activity through covalent modification of Cys residues and reveals a role of the two kinases in regulating Pol II processivity and super-enhancer-driven transcription ...

    Tinghu Zhang, Nicholas Kwiatkowski, Calla M Olson in Nature Chemical Biology (2016)

  14. No Access

    Article

    Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6

    Mig6 phosphorylation at two consecutive tyrosines induces rearrangements that lead to Mig6 sticking to and inhibiting the same EGFR that catalyzed its phosphorylation. This mechanism may serve as a basis for i...

    Eunyoung Park, Nayoung Kim, Scott B Ficarro in Nature Structural & Molecular Biology (2015)

  15. No Access

    Article

    The Cyclophilin A–CD147 complex promotes the proliferation and homing of multiple myeloma cells

    Cyclophilin A, secreted by bone marrow endothelial cells, acts as a chemotactic factor for myeloma cells, which helps explain their homing to the bone marrow and suggests a potential new therapeutic strategy.

    Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, Teresa Calimeri, Jiang Meng in Nature Medicine (2015)

  16. No Access

    Article

    Pharmacological targeting of the pseudokinase Her3

    The use of ATP competitive kinase inhibitors against the pseudokinase Her3 has been largely unsuccessful. Hydrophobic tagging of a covalent kinase inhibitor promotes Her3 degradation and prevents productive di...

    Ting **e, Sang Min Lim, Kenneth D Westover, Michael E Dodge in Nature Chemical Biology (2014)

  17. No Access

    Article

    Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

    Here, a covalent inhibitor targeting cyclin-dependent kinase 7 (CDK7) demonstrates in vitro and in vivo efficacy against T-cell acute lymphoblastic leukaemia by downregulating oncogenic transcriptional programs.

    Nicholas Kwiatkowski, Tinghu Zhang, Peter B. Rahl, Brian J. Abraham in Nature (2014)

  18. No Access

    Article

    Protected Amine Labels: A Versatile Molecular Scaffold for Multiplexed Nominal Mass and Sub-Da Isotopologue Quantitative Proteomic Reagents

    We assemble a versatile molecular scaffold from simple building blocks to create binary and multiplexed stable isotope reagents for quantitative mass spectrometry. Termed Protected Amine Labels (PAL), these re...

    Scott B. Ficarro, Jessica M. Biagi in Journal of The American Society for Mass S… (2014)

  19. No Access

    Article

    Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases

    Equivalent mutations in the pseudokinase domain of Jak2 (V617F) and Jak1 (V658F) result in myeloproliferative disorders. Crystal structures of wild-type and the V658F mutant of human Jak1 spanning the pseudoki...

    Angela V Toms, Anagha Deshpande, Randall McNally in Nature Structural & Molecular Biology (2013)

  20. No Access

    Article

    Genome-scale proteome quantification by DEEP SEQ mass spectrometry

    Advances in chemistry and massively parallel detection underlie DNA-sequencing platforms that are poised for application in personalized medicine. In stark contrast, systematic generation of protein-level data...

    Feng Zhou, Yu Lu, Scott B. Ficarro, Guillaume Adelmant in Nature Communications (2013)

previous disabled Page of 2